FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients

Clinical trial NCT03721653 · COMPLETED

Trial details

NCT number: NCT03721653
Sponsor: Gruppo Oncologico del Nord-Ovest
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2018-11-30
Primary completion: 2021-06-15
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.